Table I.
Target | Number (%) |
---|---|
Sex | |
Male | 32 (71.1) |
Female | 13 (28.9) |
Age, years | |
30–40 | 2 (4.4) |
41–50 | 15 (33.3) |
51–60 | 8 (17.8) |
>60 | 20 (44.5) |
Smoking | |
No | 31 (72.5) |
Yes | 14 (27.5) |
Symptoms | |
No symptoms | 23 (45.7) |
Cough | 14 (23.9) |
Sputum | 12 (21.7) |
Blood in sputum | 5 (8.7) |
HRCT presentation of thin-walled cysts | |
Asymmetric thickening of the wall | 37 (96.8) |
Ground-glass shadow | 4 (9.6) |
Short spicules | 13 (35.5) |
Irregular margins | 20 (51.6) |
Separation in cysts | 21 (54.8) |
Lobulation | 7 (19.3) |
Pleural indentation | 9 (22.6) |
Blood vessel convergency | 6 (16.1) |
Maximum cyst diameter, cm | |
<1 | 0 (0.0) |
1–2 | 4 (8.9) |
2.1–4 | 33 (73.3) |
>4 | 8 (17.8) |
Metastasis | |
No | 42 (93.3) |
Yes | 3 (6.7) |
Pathology | |
Adenocarcinoma | 43 (93.3) |
Squamous cell carcinoma | 2 (6.7) |
Prognosis | |
Relapse | 1 (2.2) |
Succumbed to mortality from the disease | 2 (4.5) |
Succumbed to mortality from another disease | 1 (2.2) |
Survival | 41 (91.1) |
HRCT, high-resolution computed tomography.